Mechanisms of acute kidney injury in malaria - Resubmission - 1
疟疾急性肾损伤的机制 - 重新提交 - 1
基本信息
- 批准号:10318648
- 负责人:
- 金额:$ 21.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-12-15 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Summary
Acute kidney injury (AKI) is one of the least understood but most common complications of severe pediatric
malaria and is strongly associated with increased mortality. Our previous results indicate that elevated levels of
autoimmune antibodies circulating in children with severe falciparum malaria strongly correlate with
parameters of kidney dysfunction. These results suggest that the pathogenesis of malaria-induced AKI could
be similar to classical autoimmune diseases such as systemic lupus erythematosus, where autoimmune
antibodies form immune complexes (IC) that induce kidney pathology. However, our previous work has also
identified that markers of hemolysis (free-heme and hemoglobin), correlate with the development of AKI in
African children. Hemolysis is a well-established cause of kidney injury, suggesting that lysis of erythrocytes
induced by autoimmune antibodies may also contribute to AKI.
Our overarching hypothesis is that autoimmune antibodies decisively contribute to kidney pathology in
malaria. We intend to determine the relative contribution to malaria-induce kidney pathology of two possible
autoantibody-induced mechanisms: (1) deposition of IC and (2) hemolysis-induced damage in the kidneys.
Using mice models of malaria, we will test this hypothesis and determine the role of autoantibodies in kidney
pathology. We will characterize whether IC deposition in the kidneys (aim 1.1) and/or hemolysis mediated by
autoimmune antibodies (aim 1.2) are major causes of AKI during acute malaria. We will also test the role of
neutrophil extracellular traps (NETs) in the formation of DNA-IC and in kidney dysfunction during malaria.
In aim 2 we will characterize the relationship of autoantibodies and IC with hemolysis by analyzing the relation
of the heme-axis (free-heme, hemopexin and cell-free hemoglobin, previously proposed to contribute to AKI in
malaria), oxidative stress and nitric oxide bioavailability, with acute and persistent kidney dysfunction during
malaria in a clinically well-characterized prospective cohort of 600 children with severe malaria followed for one
year.
This study will increase our understanding of kidney dysfunction in malaria both mechanistically and
epidemiologically, paving the way for the finding of new biomarkers and the development of therapies.
概括
急性肾脏损伤(AKI)是严重儿科最不知情但最常见的并发症之一
疟疾,与死亡率增加密切相关。我们先前的结果表明
严重恶性疟疾儿童循环的自身免疫性抗体与
肾功能障碍的参数。这些结果表明,疟疾引起的AKI的发病机理可以
类似于经典的自身免疫性疾病,例如全身性红斑狼疮,自身免疫性
抗体形成诱导肾脏病理学的免疫复合物(IC)。但是,我们以前的工作也
鉴定出溶血的标记(自由状 - 血红蛋白和血红蛋白)与AKI的发展相关
非洲儿童。溶血是肾脏损伤的一个公认的原因,表明红细胞裂解
自身免疫性抗体诱导的也可能导致AKI。
我们的总体假设是自身免疫性抗体果断地有助于肾脏病理学
疟疾。我们打算确定两种可能的疟疾诱导肾脏病理学的相对贡献
自身抗体诱导的机制:(1)IC和(2)溶血引起的肾脏损伤的沉积。
使用疟疾的小鼠模型,我们将检验该假设并确定自身抗体在肾脏中的作用
病理。我们将表征肾脏中的IC沉积(AIM 1.1)和/或由
自身免疫性抗体(AIM 1.2)是急性疟疾期间AKI的主要原因。我们还将测试
疟疾期间DNA-IC和肾功能障碍的中性粒细胞外陷阱(网)。
在AIM 2中,我们将通过分析关系来表征自身抗体和IC与溶血的关系
血红素轴(自由血红素,血红素和无细胞血红蛋白,先前提出的
疟疾),氧化应激和一氧化氮生物利用度,急性和持续的肾功能障碍
疟疾在临床表征良好的前瞻性队列中,有600名严重疟疾的儿童接下来
年。
这项研究将通过机械和
从流行学上讲,为寻找新的生物标志物和疗法的发展铺平了道路。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Autoantibodies during infectious diseases: Lessons from malaria applied to COVID-19 and other infections.
- DOI:10.3389/fimmu.2022.938011
- 发表时间:2022
- 期刊:
- 影响因子:7.3
- 作者:
- 通讯作者:
共 1 条
- 1
ANA RODRIGUEZ的其他基金
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists
使用 AT2 受体激动剂针对脑型疟疾期间受损的脑内皮屏障功能
- 批准号:1038627910386279
- 财政年份:2021
- 资助金额:$ 21.04万$ 21.04万
- 项目类别:
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists
使用 AT2 受体激动剂针对脑型疟疾期间受损的脑内皮屏障功能
- 批准号:1031202410312024
- 财政年份:2019
- 资助金额:$ 21.04万$ 21.04万
- 项目类别:
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists
使用 AT2 受体激动剂针对脑型疟疾期间受损的脑内皮屏障功能
- 批准号:1074158510741585
- 财政年份:2019
- 资助金额:$ 21.04万$ 21.04万
- 项目类别:
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists
使用 AT2 受体激动剂针对脑型疟疾期间受损的脑内皮屏障功能
- 批准号:1053659510536595
- 财政年份:2019
- 资助金额:$ 21.04万$ 21.04万
- 项目类别:
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists
使用 AT2 受体激动剂针对脑型疟疾期间受损的脑内皮屏障功能
- 批准号:1052824410528244
- 财政年份:2019
- 资助金额:$ 21.04万$ 21.04万
- 项目类别:
Regulation of brain endothelial integrity by angiotensin receptors as treatment for cerebral malaria
血管紧张素受体调节脑内皮完整性治疗脑型疟疾
- 批准号:1035064010350640
- 财政年份:2018
- 资助金额:$ 21.04万$ 21.04万
- 项目类别:
New Plasmodium Strategies to Modulate Inflammation
调节炎症的新疟原虫策略
- 批准号:79332717933271
- 财政年份:2009
- 资助金额:$ 21.04万$ 21.04万
- 项目类别:
New Plasmodium Strategies to Modulate Inflammation
调节炎症的新疟原虫策略
- 批准号:76579707657970
- 财政年份:2008
- 资助金额:$ 21.04万$ 21.04万
- 项目类别:
New molecules in malaria sporozoite-hepatocyte infection
疟疾子孢子-肝细胞感染的新分子
- 批准号:66785016678501
- 财政年份:2003
- 资助金额:$ 21.04万$ 21.04万
- 项目类别:
New molecules in malaria sporozoite-hepatocyte infection
疟疾子孢子-肝细胞感染的新分子
- 批准号:70122907012290
- 财政年份:2003
- 资助金额:$ 21.04万$ 21.04万
- 项目类别:
相似海外基金
Predicting the Absence of Serious Bacterial Infection in the PICU
预测 PICU 中不存在严重细菌感染
- 批准号:1080603910806039
- 财政年份:2023
- 资助金额:$ 21.04万$ 21.04万
- 项目类别:
lmmunomodulatory roles of renal lymphatic endothelial cells in Acute Kidney Injury
肾淋巴内皮细胞在急性肾损伤中的免疫调节作用
- 批准号:1061217110612171
- 财政年份:2023
- 资助金额:$ 21.04万$ 21.04万
- 项目类别:
Identifying patient subgroups and processes of care that cause outcome differences following ICU vs. ward triage among patients with acute respiratory failure and sepsis
确定急性呼吸衰竭和脓毒症患者在 ICU 与病房分诊后导致结局差异的患者亚组和护理流程
- 批准号:1073435710734357
- 财政年份:2023
- 资助金额:$ 21.04万$ 21.04万
- 项目类别:
Developing a Precision Medicine Approach to Pediatric Sepsis-Associated Acute Kidney Injury: Identification of Unique Subphenotypes and Strategies for Bedside Implementation
开发针对小儿脓毒症相关急性肾损伤的精准医学方法:识别独特的亚表型和临床实施策略
- 批准号:1072139110721391
- 财政年份:2023
- 资助金额:$ 21.04万$ 21.04万
- 项目类别:
Genetic Risk Underlying Pediatric Critical Illness
儿科危重疾病的遗传风险
- 批准号:1073999910739999
- 财政年份:2023
- 资助金额:$ 21.04万$ 21.04万
- 项目类别: